DC Bio Corp.

DC Bio Corp.

DC Bio Corp.


141 Adelaide Street West,Suite 770,Toronto, ON M5H 3L5

Type of Company




Company Description

DC Bio Corp. develops technology for application to cancer and diseases associated with chronic viral infections. The company is headquartered in Toronto, Canada.

Executives & Employees


Paths to DC Bio Corp.
Potential Connections via
Relationship Science
DC Bio Corp.
Details Hidden

Medical Discovery Management Corp. manages the Canadian Medical Discoveries Fund (CMDF), a venture capital fund focused on the health science sector including life sciences, biotechnology, diagnostics, medical devices, drug discovery and development, health care delivery services and e-health. The Fund invests in technologies and intellectual property that are significant in the global marketplace and focuses on businesses involved in the testing and development or production and commercialization stages of development which have significant potential for growth. CMDF seeks investments that will provide at least a 30% annualized return. Expected time horizon for a liquid market, merger or acquisition is 2 to 4 years

Details Hidden

Argos Therapeutics, Inc. is a biopharmaceutical company, which engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. Its product candidates include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Ralph Steinman on May 8, 1997 and is headquartered in Durham, NC.

Details Hidden

GrowthWorks Capital specializes in the management of regionally-based venture capital funds (RVCs). The firm's managed funds invest in small and medium-sized Canadian businesses with high growth potential. They manage funds that rigorously follow core principles: (1) structure strategic investments in growth-oriented companies (2) value portfolio assets conservatively (3) build vital industry connections and (4) minimize risk through diversification. GrowthWorks invests in Canadian firms in the following sectors: information technology, life sciences, advanced materials and clean technology.GrowthWorks usually invests for a minority ownership position. They also anticipate the need for follow-on investments to support continued growth. The firm often partners with other venture capital funds and strategic partners to raise larger amounts of capital.The Working Opportunity Fund Commercialization Fund offers extra tax savings of up to 30% with the added bonus of dividend payments of up to 25% over a three-year period. The Working Opportunity Fund is available to all British Columbians. The Fund is a long-term investment and does have a hold period. It invests in fast growing British Columbia companies in the information technology, life sciences and clean technology sectors. The Fund looks for companies with strong management teams, the potential for sustainable advantages and a technological innovation for a large and growing market.The GrowthWorks Commercialization Fund seeks long-term capital appreciation through investments primarily in a portfolio of small- and medium-sized Canadian companies. It is a research-oriented investment fund that seeks to identify and invest in early-stage research-oriented companies with significant commercialization potential.The GrowthWorks Atlantic Venture Fund invests in emerging growth businesses throughout the Atlantic Provinces of Canada.The GrowthWorks Canadian Fund is a national retail venture capital fund. The Fund is an RRSP eligible investment available for purchase by residents of Alberta, Saskatchewan, Manitoba, Ontario, Northwest Territories, Yukon and Nunavut through Investment advisors and discount brokerages.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by DC Bio Corp.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of DC Bio Corp.'s profile does not indicate a business or promotional relationship of any kind between RelSci and DC Bio Corp..